Ensuring ADC bioanalysis accuracy

Antibody‑drug conjugates (ADCs) pose significant bioanalytical challenges due to their structural complexity, heterogeneous drug‑to‑antibody ratios, and the need for precise quantification across multiple analytes. These hurdles can compromise data accuracy, delay development, and complicate regulatory submissions.

Explore how advanced LC‑MS workflows, optimized sample preparation, and robust analytical strategies improve ADC bioanalysis accuracy. Plus, read real‑world case studies demonstrating how leading teams apply these methods to strengthen data quality and streamline development.